TNF and inflammatory bowel disease: The therapeutic landscape of IBD has evolved over the past few decades with the introduction of monoclonal antibodies against tumor necrosis factor-alpha (TNF-α), integrin-α4β7, and interleukin (IL)-12/23 p40.3